{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["LC\u2212MS/MS", "in silico metabolite prediction", "metabolites", "pharmacokinetic", "rats"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36558934", "DateRevised": {"Year": "2022", "Month": "12", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "11", "Day": "29"}], "Language": ["eng"], "ELocationID": ["1483", "10.3390/ph15121483"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "15", "Issue": "12", "PubDate": {"Year": "2022", "Month": "Nov", "Day": "29"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Pharmacokinetic Study and Metabolite Identification of 1-(3'-bromophenyl)-heliamine in Rats.", "Abstract": {"AbstractText": ["Tetrahydroisoquinolines have been widely investigated for the treatment of arrhythmias. 1-(3'-bromophenyl)-heliamine (BH), an anti-arrhythmias agent, is a synthetic tetrahydroisoquinoline. This study focuses on the pharmacokinetic characterization of BH, as well as the identification of its metabolites, both in vitro and in vivo. A UHPLC-MS/MS method was developed and validated to quantify BH in rat plasma with a linear range of 1-1000 ng/mL. The validated method was applied to a pharmacokinetic study in rats. The maximum concentration C<sub>max</sub> (568.65 \u00b1 122.14 ng/mL) reached 1.00 \u00b1 0.45 h after oral administration. The main metabolic pathways appeared to be phase-I of demethylation, dehydrogenation, and epoxidation, and phase II of glucuronide and sulfate metabolites. Finally, a total of 18 metabolites were characterized, including 10 phase I metabolites and 8 phase II metabolites. Through the above studies, we have gained a better understanding of the absorption and metabolism of BH in vitro and in vivo, which will provide us with guidance for future in-depth studies on this compound."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, CAS Key Laboratory of Chemistry of Plant Resources in Arid Regions, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, No. 19 (A) Yuquan Road, Shijingshan District, Beijing 100049, China."}], "LastName": "Xi", "ForeName": "Ruqi", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, CAS Key Laboratory of Chemistry of Plant Resources in Arid Regions, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China."}], "LastName": "Abdulla", "ForeName": "Rahima", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, CAS Key Laboratory of Chemistry of Plant Resources in Arid Regions, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China."}, {"Identifier": [], "Affiliation": "University of Chinese Academy of Sciences, No. 19 (A) Yuquan Road, Shijingshan District, Beijing 100049, China."}], "LastName": "Zhang", "ForeName": "Miaomiao", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "S. Yu. Yunusov Institute of the Chemistry of Plant Substances, Academy of Sciences of the Republic of Uzbekistan, Tashkent 100170, Uzbekistan."}], "LastName": "Sherzod", "ForeName": "Zhurakulov", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "S. Yu. Yunusov Institute of the Chemistry of Plant Substances, Academy of Sciences of the Republic of Uzbekistan, Tashkent 100170, Uzbekistan."}], "LastName": "Ivanovna", "ForeName": "Vinogradova Valentina", "Initials": "VV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, CAS Key Laboratory of Chemistry of Plant Resources in Arid Regions, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China."}], "LastName": "Habasi", "ForeName": "Maidina", "Initials": "M"}, {"Identifier": ["0000-0002-2144-4474"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, CAS Key Laboratory of Chemistry of Plant Resources in Arid Regions, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China."}], "LastName": "Liu", "ForeName": "Yongqiang", "Initials": "Y"}], "GrantList": [{"GrantID": "2021YFE0104000", "Agency": "National Key R&amp;D Program of China", "Country": ""}, {"GrantID": "2022E01007", "Agency": "Xinjiang Uygur Autonomous Region Regional Collaborative Innovation Special Project", "Country": ""}, {"GrantID": "2020YFE0205600", "Agency": "National Key R&amp;D Program of China", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Dehghan M., Mente A., Zhang X., Swaminathan S., Li W., Mohan V., Iqbal R., Kumar R., Wentzel-Viljoen E., Rosengren A., et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): A prospective cohort study. Lancet. 2017;390:2050\u20132062. doi: 10.1016/S0140-6736(17)32252-3.", "ArticleIdList": ["10.1016/S0140-6736(17)32252-3", "28864332"]}, {"Citation": "Report on cardiovascular health and diseases in China 2021: An updated summary. Chin. Health Econ. 2022;37:533\u2013578."}, {"Citation": "Shi Y., Zhang H., Huang S., Yin L., Wang F., Luo P., Huang H. Epigenetic regulation in cardiovascular disease: Mechanisms and advances in clinical trials. Signal Transduct. Target. Ther. 2022;7:1\u201328. doi: 10.1038/s41392-022-01055-2.", "ArticleIdList": ["10.1038/s41392-022-01055-2", "PMC9233709", "35752619"]}, {"Citation": "Jacob V., Reynolds J.A., Chattopadhyay S.K., Hopkins D.P., Therrien N.L., Jones C.D., Durthaler J.M., Rask K.J., Cuellar A.E., Clymer J.M., et al. Pharmacist interventions for medication adherence: Community guide economic reviews for cardiovascular disease. Am. J. Prev. Med. 2022;62:E202\u2013E222. doi: 10.1016/j.amepre.2021.08.021.", "ArticleIdList": ["10.1016/j.amepre.2021.08.021", "PMC8863641", "34876318"]}, {"Citation": "Roth G.A., Mensah G.A., Fuster V. The global burden of cardiovascular diseases and risks. J. Am. Coll. Cardiol. 2020;76:2980\u20132981. doi: 10.1016/j.jacc.2020.11.021.", "ArticleIdList": ["10.1016/j.jacc.2020.11.021", "33309174"]}, {"Citation": "World Health Organization  World Health Statistics 2022: Monitoring Health for the SDGs, Sustainable Development Goals.  [(accessed on 10 October 2022)].  Available online:  https://www.who.int/publications/i/item/9789240027053."}, {"Citation": "Yi T.W., Levin A. Sex, gender, and cardiovascular disease in chronic kidney disease. Semin. Nephrol. 2022;42:197\u2013207. doi: 10.1016/j.semnephrol.2022.04.009.", "ArticleIdList": ["10.1016/j.semnephrol.2022.04.009", "35718366"]}, {"Citation": "Zhang Y., Zhai T., Chai P., Hwang Y., Wan Q. Study on accounting and projection of curative expenditure on cardiovascular and cerebrovascular diseases in China. Chin. Health Econ. 2019;38:18\u201322."}, {"Citation": "Shaw L.J., Goyal A., Mehta C., Xie J., Phillips L., Kelkar A., Knapper J., Berman D.S., Nasir K., Veledar E., et al. 10-Year resource utilization and costs for cardiovascular care. J. Am. Coll. Cardiol. 2018;71:1078\u20131089. doi: 10.1016/j.jacc.2017.12.064.", "ArticleIdList": ["10.1016/j.jacc.2017.12.064", "PMC5846485", "29519347"]}, {"Citation": "Hashimoto K. Arrhythmia models for drug research: Classification of antiarrhythmic drugs. J. Pharmacol. Sci. 2007;103:333\u2013346. doi: 10.1254/jphs.CRJ06013X.", "ArticleIdList": ["10.1254/jphs.CRJ06013X", "17409630"]}, {"Citation": "Langenfeld H., Weirich J., K\u00f6hler C., Kochsiek K. Atrioventricular differences in the class I effect of antiarrhythmic drugs (prajmaline,propafenone,quindine) Eur. J. Pharmacol. 1990;183:1163. doi: 10.1016/0014-2999(90)94251-R.", "ArticleIdList": ["10.1016/0014-2999(90)94251-R"]}, {"Citation": "Al-Hashimi M., Thompson J.P. Drugs acting on the heart: Anti-arrhythmics. Anaesth. Intensive Care Med. 2012;13:374\u2013377. doi: 10.1016/j.mpaic.2012.05.002.", "ArticleIdList": ["10.1016/j.mpaic.2012.05.002"]}, {"Citation": "Dong H., Lee C.M., Huang W.L., Peng S.X. World Health Organization cardiovascular effects of substituted tetrahydroisoquinolines in rats. Br. J. Pharmacol. 1992;107:262\u2013268. doi: 10.1111/j.1476-5381.1992.tb14496.x.", "ArticleIdList": ["10.1111/j.1476-5381.1992.tb14496.x", "PMC1907609", "1330162"]}, {"Citation": "Dong H., Waldron G.J., Cole W.C., Triggle C.R. Cardiovascular pharmacology of CPU-23: A novel calcium channel blocker. Cardiovasc. Drug Rev. 1996;14:364\u2013379. doi: 10.1111/j.1527-3466.1996.tb00319.x.", "ArticleIdList": ["10.1111/j.1527-3466.1996.tb00319.x"]}, {"Citation": "Wu S., Yu X., Shan J., Wong T., Chen C., Pang K. Cardiac effects of the extract and active components of radix stephaniae tetrandrae I. Electrically-induced intracellular calcium transient and protein release during the calcium paradox. Life Sci. 2001;68:2853\u20132861. doi: 10.1016/S0024-3205(01)01068-2.", "ArticleIdList": ["10.1016/S0024-3205(01)01068-2", "11432451"]}, {"Citation": "Wang L.-H., Li X.-L., Li Q., Fu Y., Yu H.-J., Sun Y.-Q., Zhang L., Shan H.-L. Berberine alleviates ischemic arrhythmias via recovering depressed Ito and ICa currents in diabetic rats. Phytomedicine. 2012;19:206\u2013210. doi: 10.1016/j.phymed.2011.11.002.", "ArticleIdList": ["10.1016/j.phymed.2011.11.002", "22188769"]}, {"Citation": "Wang Y.X., Zheng Y.M. Ionic mechanism responsible for prolongation of cardiac action-potential duration by berberine. J. Cardiovasc. Pharmacol. 1997;30:214\u2013222. doi: 10.1097/00005344-199708000-00010.", "ArticleIdList": ["10.1097/00005344-199708000-00010", "9269949"]}, {"Citation": "Zhu J.Q., Zeng F.D., Hu C.J. Prothcive and antiarrhythmic effects of dauricine and verapamil on acute myocardial-infarction in anesthetized dogs. Acta Pharmacol. Sin. 1992;13:249\u2013251.", "ArticleIdList": ["1442108"]}, {"Citation": "Song L.-S., Ren G.-J., Chen Z.-L., Chen Z.-H., Zhou Z.-N., Cheng H. Electrophysiological effects of protopine in cardiac myocytes: Inhibition of multiple cation channel currents. Br. J. Pharmacol. 2000;129:893\u2013900. doi: 10.1038/sj.bjp.0703132.", "ArticleIdList": ["10.1038/sj.bjp.0703132", "PMC1571915", "10696087"]}, {"Citation": "Zhurakulov S.N., Vinogradova V.I., Levkovich M.G. Synthesis of 1-aryltetrahydroisoquinoline alkaloids and their analogs. Chem. Nat. Compd. 2013;49:70\u201374. doi: 10.1007/s10600-013-0507-2.", "ArticleIdList": ["10.1007/s10600-013-0507-2"]}, {"Citation": "Jumaev I.Z., Jurakulov S.N., Usmanov P.B. The inotropic effect of 1-(4-dimetylaminophenyl)-6,7-dimetoxy-1,2,3,4-tetrahydroisoquinoline (F24) Pharm. J. 2018;4:93\u201397."}, {"Citation": "Jumayev I., Usmanov P., Rustamov S., Zhurakulov S. Comparative inotropic effects of the some isoquinoline alkaloids. Biomed. Pharmacother. 2020;13:325\u2013333. doi: 10.13005/bpj/1892.", "ArticleIdList": ["10.13005/bpj/1892"]}, {"Citation": "Davies B., Morris T. Physiological-parameters in laboratory-animals and humans. Pharm. Res. 1993;10:1093\u20131095. doi: 10.1023/A:1018943613122.", "ArticleIdList": ["10.1023/A:1018943613122", "8378254"]}, {"Citation": "Zaretzki J., Matlock M., Swamidass S.J. Xenosite: Accurately predicting CYP-mediated sites of metabolism with neural networks. J. Chem. Inf. Model. 2013;53:3373\u20133383. doi: 10.1021/ci400518g.", "ArticleIdList": ["10.1021/ci400518g", "24224933"]}, {"Citation": "DiMasi J.A., Grabowski H.G., Hansen R.W. Innovation in the pharmaceutical industry: New estimates of R&D costs. J. Health Econ. 2016;47:20\u201333.", "ArticleIdList": ["26928437"]}, {"Citation": "Paul S.M., Mytelka D.S., Dunwiddie C.T., Persinger C.C., Munos B.H., Lindborg S.R., Schacht A.L. How to improve R&D productivity: The pharmaceutical industry\u2019s grand challenge. Nat. Rev. Drug Discov. 2010;9:203\u2013214.", "ArticleIdList": ["20168317"]}, {"Citation": "Kazmi S.R., Jun R., Yu M.-S., Jung C., Na D. In silico approaches and tools for the prediction of drug metabolism and fate: A review. Comput. Biol. Med. 2019;106:54\u201364. doi: 10.1016/j.compbiomed.2019.01.008.", "ArticleIdList": ["10.1016/j.compbiomed.2019.01.008", "30682640"]}, {"Citation": "Hughes T.B., Miller G.P., Swamidass S.J. Modeling epoxidation of drug-like molecules with a deep machine learning network. ACS Cent. Sci. 2015;1:168\u2013180. doi: 10.1021/acscentsci.5b00131.", "ArticleIdList": ["10.1021/acscentsci.5b00131", "PMC4827534", "27162970"]}, {"Citation": "Dang N.L., Hughes T.B., Krishnamurthy V., Swamidass S.J. A simple model predicts UGT-mediated metabolism. Bioinformatics. 2016;32:3183\u20133189. doi: 10.1093/bioinformatics/btw350.", "ArticleIdList": ["10.1093/bioinformatics/btw350", "PMC5939911", "27324196"]}, {"Citation": "Rydberg P., Gloriam D.E., Zaretzki J., Breneman C., Olsen L. Oxidative medicine and cellular longevity SMARTCyp: A2D method for prediction of cytochrome P450-mediated drug metabolism. ACS Med. Chem. Lett. 2010;1:96\u2013100. doi: 10.1021/ml100016x.", "ArticleIdList": ["10.1021/ml100016x", "PMC4055970", "24936230"]}, {"Citation": "Zaretzki J., Rydberg P., Bergeron C., Bennett K.P., Olsen L., Breneman C.M. RS-predictor models augmented with SMARTCyp reactivities: Robust metabolic regioselectivity predictions for nine CYP Isozymes. J. Chem. Inf. Model. 2012;52:1637\u20131659. doi: 10.1021/ci300009z.", "ArticleIdList": ["10.1021/ci300009z", "PMC3449220", "22524152"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "18"}, {"Year": "2022", "Month": "11", "Day": "21"}, {"Year": "2022", "Month": "11", "Day": "22"}, {"Year": "2022", "Month": "12", "Day": "23", "Hour": "1", "Minute": "55"}, {"Year": "2022", "Month": "12", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "11", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["36558934", "PMC9781129", "10.3390/ph15121483", "ph15121483"]}}], "PubmedBookArticle": []}